Antabuse: A Clinically Proven Aid for Alcohol Dependence Recovery
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.51 | $46.02 (0%) | 🛒 Add to cart |
| 120 | $0.48 | $61.36 $57.02 (7%) | 🛒 Add to cart |
| 180 | $0.46 | $92.03 $82.03 (11%) | 🛒 Add to cart |
| 270 | $0.44 | $138.05 $118.04 (14%) | 🛒 Add to cart |
| 360 | $0.43
Best per pill | $184.07 $153.05 (17%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.95 | $57.02 (0%) | 🛒 Add to cart |
| 90 | $0.84 | $85.53 $76.03 (11%) | 🛒 Add to cart |
| 120 | $0.78 | $114.04 $94.03 (18%) | 🛒 Add to cart |
| 180 | $0.72 | $171.06 $130.05 (24%) | 🛒 Add to cart |
| 270 | $0.69 | $256.59 $185.07 (28%) | 🛒 Add to cart |
| 360 | $0.67
Best per pill | $342.12 $242.09 (29%) | 🛒 Add to cart |
Synonyms | |||
Antabuse (disulfiram) is a prescription medication designed to support individuals committed to maintaining abstinence from alcohol. It functions as an aversive therapy by producing a highly unpleasant physiological reaction if alcohol is consumed, thereby creating a powerful psychological deterrent. This pharmacological intervention is a cornerstone of comprehensive treatment plans for alcohol use disorder (AUD), intended for use under strict medical supervision alongside counseling and behavioral support. Its efficacy is well-established in clinical practice for motivated patients within a structured therapeutic framework.
Features
- Active Pharmaceutical Ingredient: Disulfiram.
- Mechanism of Action: Irreversible inhibition of the enzyme aldehyde dehydrogenase (ALDH).
- Administration: Oral tablet.
- Available Strengths: 250 mg and 500 mg tablets.
- Prescription Status: Available only by prescription.
- Onset of Action: The disulfiram-ethanol reaction (DER) can occur within 5-10 minutes of alcohol ingestion.
- Duration of Effect: The sensitization to alcohol can persist for up to 14 days after the last dose due to the irreversible nature of enzyme inhibition.
Benefits
- Creates a Powerful Psychological Deterrent: The certainty of an adverse physical reaction provides a strong external motivator to resist alcohol consumption, helping patients navigate cravings and high-risk situations.
- Supports Behavioral Therapy: Serves as a tangible tool within a broader treatment plan, reinforcing the commitment to sobriety made during counseling sessions.
- Provides a Structured Framework for Recovery: The daily act of taking the medication can help establish a routine and maintain a constant awareness of the recovery journey.
- Empowers Patient Control: By making the consequences of drinking immediate and predictable, it returns a sense of agency to the patient, breaking the cycle of compulsive use.
- Facilitates Periods of Forced Abstinence: Can be crucial for creating a necessary window of abstinence, allowing other therapeutic interventions to become more effective.
Common use
Antabuse is indicated as an adjunctive therapy in the management of selected patients with severe, chronic alcohol use disorder who wish to remain in a state of enforced sobriety. It is not a cure for alcoholism and does not reduce the craving for alcohol. Its use is predicated on the patient’s full knowledge of the consequences of alcohol consumption while on the medication and their voluntary, informed consent to treatment. It is most effective when integrated into a comprehensive treatment program that includes psychological support, counseling, and social rehabilitation.
Dosage and direction
Initial Dosage: The maximum recommended initial dose for the first one to two weeks of therapy is 500 mg daily, administered orally as a single dose in the morning. Maintenance Dosage: The daily dosage may be reduced to 250 mg (or occasionally 125 mg). The maintenance dose must be individually tailored, ranging from 125 mg to 500 mg daily. The lower end of the dosing range is often sufficient for maintenance and may reduce the incidence of adverse effects. Administration Guidance:
- The tablet should be swallowed whole with water.
- It is typically taken in the morning to coincide with the resolve of a new day. If sedation occurs, taking the dose at bedtime may be considered.
- Treatment should not be initiated until the patient has abstained from alcohol for at least 12 hours and a physician has ascertained the absence of alcohol via breath or blood test.
- The duration of treatment must be determined by the prescribing physician and is contingent upon the patient’s ongoing commitment and progress in therapy.
Precautions
- Informed Consent is Paramount: The patient must be fully advised and comprehend the nature and risks of the disulfiram-ethanol reaction. A written consent form is often used.
- Supervised Administration: Especially in the initial phases, administration by a spouse or healthcare professional may be advised to ensure compliance.
- Liver Function Monitoring: Baseline liver function tests (LFTs) are mandatory before initiation. LFTs should be repeated at 10-14 days, and then periodically (e.g., every 3-6 months) throughout therapy due to the risk of hepatotoxicity.
- Psychiatric Status: Patients should be monitored for the emergence of depression, psychotic reactions, or other significant changes in mental status.
- Occupational Hazards: Caution is advised for patients working with organic solvents or chemicals (e.g., painters, mechanics) as these can sometimes contain alcohol and potentially trigger a reaction.
- Pregnancy and Lactation: Antabuse is contraindicated in pregnancy. The risks and benefits must be carefully weighed in women of childbearing potential.
Contraindications
- Hypersensitivity to disulfiram or any other components of the formulation.
- Severe myocardial disease or coronary occlusion.
- Psychosis.
- Current or recent use of metronidazole, paraldehyde, alcohol, or alcohol-containing preparations (e.g., elixirs, tonics, cough syrups, food extracts).
- Pregnancy.
Possible side effect
Common:
- Drowsiness, fatigue, headache.
- Metallic or garlic-like aftertaste (especially in the first weeks of therapy).
- Acneiform eruptions, allergic dermatitis.
- Impotence.
Less Common but Serious:
- Hepatotoxicity: Ranging from transient transaminase elevations to hepatitis, cholestasis, and fulminant hepatic failure, which can be fatal.
- Neuropathy: Peripheral neuropathy, including optic neuritis, which may present with numbness or paresthesia in limbs.
- Psychiatric Effects: Polyneuritic psychosis, depression, manic episodes, confusion, memory impairment.
- Dermatological: Exfoliative dermatitis.
Drug interaction
Antabuse inhibits several hepatic enzyme systems, leading to numerous potential interactions:
- Warfarin: Disulfiram potentiates the anticoagulant effect by inhibiting its metabolism, increasing the risk of bleeding. Prothrombin time must be monitored closely, and warfarin dosage will likely need reduction.
- Phenytoin: Disulfiram inhibits the metabolism of phenytoin, significantly increasing its serum levels and risk of toxicity (e.g., nystagmus, ataxia). Phenytoin levels must be monitored.
- Benzodiazepines: Metabolism of certain benzodiazepines (e.g., chlordiazepoxide, diazepam) may be inhibited, potentiating their sedative effects.
- Tricyclic Antidepressants: Metabolism may be inhibited.
- Isoniazid: Increased risk of unsteadiness, dizziness, and behavioral changes.
- Theophylline: Disulfiram may decrease theophylline clearance, increasing the risk of toxicity.
- CNS Depressants: Additive effects with other sedating drugs.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. However, if it is not remembered until the next day, the missed dose should be skipped. The patient should never double the dose to make up for a missed one. Consistency is key for maintaining the enzyme blockade. The patient should inform their physician or therapist of any missed doses.
Overdose
Symptoms: Overdose primarily manifests as neurological toxicity, including nausea, vomiting, dizziness, ataxia, seizures, and coma. The disulfiram-ethanol reaction is not a feature of overdose in the absence of ethanol. Management: There is no specific antidote for disulfiram overdose. Treatment is entirely supportive and symptomatic. Gastric lavage may be considered if presentation is immediate. Support of respiratory and cardiovascular functions is critical. Management of seizures with benzodiazepines may be necessary. Given the risk of hepatotoxicity, liver function must be closely monitored.
Storage
- Store at controlled room temperature, 20°C to 25°C (68°F to 77°F).
- Protect from light and moisture. Keep the bottle tightly closed.
- Keep out of reach of children and pets.
- Do not flush medication down the toilet or pour it into a drain. Dispose of unused medication via a official medicine take-back program.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The author does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned.
Reviews
- “As an addiction specialist for over 20 years, I reserve Antabuse for highly motivated patients within a structured program. It is not a magic bullet, but for the right individual, it provides the necessary ‘circuit breaker’ to establish sustained abstinence. The key is patient selection and comprehensive support.” – Dr. A., MD, Psychiatry
- “The pharmacological deterrent provided by disulfiram was the critical component that allowed me to break my cycle of relapse. Knowing the severe consequences of a drink removed the internal debate and gave me the space to focus on my therapy. It’s a powerful tool, but you have to be ready to use it.” – Patient J., 4 years sober
- “While effective, the potential for hepatotoxicity requires vigilant monitoring. I would not prescribe this medication without ensuring full patient comprehension of the risks and a commitment to regular follow-up and blood tests. It demands a strong therapeutic alliance.” – Dr. L., Hepatologist